Search clinical trials for: IFN-a-2a

Total 20137 results

Hospital Clinico Universitario San Cecilio

Completed

Efficacy and Safety to Extend Treatment 24 Weeks in co-Infected HIV-HCV Genotype 1 and/or 4

HIV Infections | Hepatitis C

Spain
Janssen R&D Ireland

Completed

An Efficacy, Safety, and Tolerability Study of TMC435 in Treatment-naive, Genotype 1 Hepatitis C-infected Participants (QUEST-2)

Hepatitis C

United States, France, Poland, Belgium, Germany, Spain, Portugal, Bulgaria, Turkey, Argentina, Brazil, Austria, Netherlands, Slovakia, Puerto Rico
Novira Therapeutics, Inc.

Completed

Safety and Efficacy Study of NVR 3-778 in Healthy Volunteers and Hepatitis B Patients

Chronic Hepatitis B

New Zealand
Novira Therapeutics, Inc.

Completed

Dose-Ranging Study to Assess the Safety, PK and Initial Antiviral Efficacy of NVR 3-778 in Chronic HBV Patients

Chronic Hepatitis B

United States, Taiwan, Singapore, Korea, Republic of, China
Májbetegekért Alapítvány
Hoffmann-La Roche

Unknown

Continuing Treatment With Pegasys and Copegus

Chronic Hepatitis C

Hungary
Hoffmann-La Roche
Roche Pharma AG

Completed

Influence of Ribavirin on the Initial Virological Response in Treatment Naïve Patients With Hepatitis C Genotype 1 Infection

Hepatitis C, Chronic

Germany
Charite University, Berlin, Germany
Karl and Veronica Carstens Foundation

Completed

Effectiveness of Local Application of Warm Air in Patients With Common Cold (HELI Study) (HELI)

Common Cold

Germany
University Hospital, Angers
Société Française de Médecine Vasculaire

Completed

Locomotion and Global Positioning System in Arterial Disease (Starter-GPS)

Peripheral Arterial Disease

France
Hoffmann-La Roche

Completed

A Study Evaluating Slow Response/Non-Rapid Response in Patients With Chronic Hepatitis C, Genotype 1, 2, 3 & 4 Treated With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin)

Hepatitis C, Chronic

Israel
Hoffmann-La Roche

Completed

A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Ribavirin in Hemophiliac Patients With Chronic Hepatitis C.

Hepatitis C, Chronic

Mexico
University of New Mexico

Completed

"Facemask Use During High-intensity Interval Exercise in Temperate and Hot Environments"

Hypoxemia | Physiological Stress

United States
Novartis Pharmaceuticals

Completed

A Study of BEZ235 in Adult Japanese Patients With Advanced Solid Tumors

Advanced Solid Tumor

Japan
Samsung Medical Center

Terminated

Graft Patency Analysis of the Right Coronary Artery System

Coronary Artery Disease

Korea, Republic of
Hoffmann-La Roche

Completed

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Hepatitis B, Chronic

Belgium, United States, Israel, China, Australia, Germany, Russian Federation, Ukraine, United Kingdom, Poland, Bulgaria, Italy
Hoffmann-La Roche

Completed

A Study of Ribavirin in Combination With PEGASYS (Peginterferon Alfa-2a (40KD))in Patients With Chronic Hepatitis C

Hepatitis C, Chronic

Russian Federation
National Taiwan University Hospital
Hoffmann-La Roche

Unknown

Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C

Hepatitis C, Chronic | Hepatitis B, Chronic

Taiwan
Hoffmann-La Roche

Terminated

An Observational Study of Pegasys (Peginterferon Alfa-2a) Plus Ribavirin Based Regimens in Patients With Chronic Hepatitis C With Previous Treatment Failure

Hepatitis C, Chronic

Romania
Janssen R&D Ireland

Completed

An Efficacy, Safety and Tolerability Study of TMC435 in Genotype 1 Hepatitis C-infected Patients Who Relapsed After Previous Therapy (PROMISE)

Hepatitis C

United States, Australia, France, Poland, United Kingdom, Belgium, Germany, Spain, Canada, New Zealand, Russian Federation, Puerto Rico, Austria
Assiut University

Not yet recruiting

Urinary Activin A as Apredictive Marker for Assessement of Acute Kidney Injury Severity in Patient Admitted at Assuit University Hospital

Urinary Activin A in AKI
Yale University
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

The LEARN Study for CVD Prevention (LEARN)

Cardiovascular Diseases

United States
National University of Ireland, Galway, Ireland
Health Research Board, Ireland

Recruiting

Comparison of Multi-Round and Real-Time Delphi Survey Methods

Consensus Development

Ireland
Aalborg University Hospital

Completed

Prevalence of Positional Nystagmus in a Population of Healthy Adults

Healthy Volunteers | Positional Nystagmus

Denmark
University of Pennsylvania

Completed

Design of an Affordable Gym for Post Stroke Rehabilitation (RehabCares)

Stroke | Healthy | Cerebral Palsy

United States
Institute of Mountain Emergency Medicine

Completed

Suspension Syndrome

Orthostatic Hypotension | Circulatory Failure | Syncope, Vasovagal, Neurally-Mediated | Circulatory Collapse
National Institute of Diabetes and Digestive and...
National Cancer Institute (NCI); National Institute on Minority Health and... and other collaborators

Completed

Hepatitis C Antiviral Resistance in African-Americans

Hepatitis C

United States
Medstar Health Research Institute

Completed

Assessment of Postpartum Education to Improve Compliance

Hypertension in Pregnancy | Postpartum Preeclampsia

United States
Fudan University

Active, not recruiting

Acute Health Effects of Traffic-Related Air Pollution Exposure

Cardiovascular System | Respiratory System

China
Centre Hospitalier Intercommunal Creteil

Completed

Influence of the "Atelier du rêve" (Dream Workshop) on the Quality of Falling Asleep in the Operating Room. (REVA)

Anesthesia

France
Hoffmann-La Roche

Active, not recruiting

A Trial To Evaluate The Efficacy And Safety Of Multiple Combination Therapies In Participants With Chronic Hepatitis B (Piranga)

Hepatitis B, Chronic

Taiwan, Canada, Korea, Republic of, Thailand, United Kingdom, China, United States, Bulgaria, Spain, New Zealand, Hong Kong, Romania, Chile, France
Duke University

Terminated

Pilot Study of Interferon Alfa for Patients Who Have Received Cancer Vaccines

Cancer
Uppsala University

Completed

PFN-A Augmentation for Intertrochanteric Femoral Fractures

Intertrochanteric Fracture

Sweden
French Innovative Leukemia Organisation

Completed

Trial Ruxolitinib and Peg-interferon Alpha-2a Combination in Patients With Primary Myelofibrosis RUXOPeg (RUXOPeg)

Myelofibrosis

France
Xiamen Amoytop Biotech Co., Ltd.
Peking University First Hospital

Completed

Long-term Benefit in Chronic Hepatitis B Patients After Standard Peginterferon Alfa Therapy

Hepatitis B

China
Hoffmann-La Roche

Completed

A Study of Sustained Virological Response in Relation to IL28-b Expression in Treatment-Naïve Patients With Chronic Hepatitis C Genotype 1 on Combination Treatment With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin)

Hepatitis C, Chronic

Brazil
Chinese University of Hong Kong

Completed

An Open-label Trial of 48-week Peginterferon Alfa-2a (PEGASYS) to Assess the Sustained Response of Chronic Hepatitis B Patients With HBeAg Seroconversion on Nucleot(s)Ide Analogue Therapy

Chronic Hepaititis B

Hong Kong
Casa Sollievo della Sofferenza IRCCS
University of Palermo; University of Florence; Campus Bio-Medico University; IRCCS... and other collaborators

Completed

Different Ribavirin Dosages and Different Duration of Treatment in Combination With PegInterferon in Patients With Genotype 2 and 3 (WRITE) (WRITE)

Chronic Hepatitis

Italy
The Wistar Institute
National Institute of Allergy and Infectious Diseases (NIAID); Hoffmann-La... and other collaborators

Completed

Antiviral Activity of Peg-IFN-Alpha-2A in Chronic HIV-1 Infection

HIV Infections

United States
Baqiyatallah Medical Sciences University
Guilan University of Medical Sciences; Baqiyatallah Research Center for Gastroenterology... and other collaborators

Completed

Pegasys® Plus Ribavirin in Thalassemic Patients With Hepatitis C Virus Infection

Hepatitis C | Thalassemia

Iran, Islamic Republic of
Hospital Hietzing
Medical University of Vienna

Completed

Quality of Life in Juvenile Patients With Uveitis

Uveitis

Austria
Hospital Hietzing
Medical University of Graz

Unknown

Acute Anterior Uveitis: Psychic Burden and Pain

Anterior Uveitis

Austria
Vertex Pharmaceuticals Incorporated

Terminated

A Safety and Efficacy Study of the Combination of VX-222 and Telaprevir in Treatment-Naïve Subjects With Genotype 1 Chronic Hepatitis C Virus Infection

Chronic Hepatitis C Virus Infection

United States, New Zealand
Third Affiliated Hospital, Sun Yat-Sen University
Peking University; Huazhong University of Science and Technology; First People... and other collaborators

Unknown

The Optimizing Treatment of Peginterferon (PEG IFN) Alpha in Chronic Hepatitis B Virus Patients With Low Level HBsAg

Chronic Hepatitis B

China
Hoffmann-La Roche

Completed

A Study of RO5024048 in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients With Chronic Hepatitis C Genotype 1 or 4

Hepatitis C, Chronic

United States, Canada
Hoffmann-La Roche

Completed

PROPHESYS 3: Observational Study on Predictors of Response in Patients With Treatment-naïve Chronic Hepatitis C Initiated on Treatment With Pegasys (Peginterferon Alfa-2a) or Peginterferon-alfa-2b

Hepatitis C, Chronic

United States, Puerto Rico
Wake Forest University Health Sciences

Withdrawn

MED in UVB Devices in the Presence and Absence of UV Filter

Healthy Participants and/or Patients

United States
Hoffmann-La Roche

Completed

POTENTE Study: A Study of Early Virological Response in Naive Patients With Chronic Hepatitis C, Genotype 2 or 3, Treated With PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Copegus (Ribavirin).

Hepatitis C, Chronic

Brazil
Vertex Pharmaceuticals Incorporated

Completed

Phase 2 Study of VX-950, Pegasys and Copegus in Hepatitis C

Hepatitis C

United States, Puerto Rico
Memorial Sloan Kettering Cancer Center

Recruiting

Characterization of Hyperpolarized Pyruvate MRI Reproducibility

Malignant Solid Tumors

United States
Janssen Pharmaceutical K.K.

Completed

A Phase III Study of TMC435 in Genotype 1, Hepatitis C-infected Participants Who Failed to Respond to Previous IFN-based Therapy

Hepatitis C, Chronic

Japan
National Taiwan University Hospital
National Science Council, Taiwan

Completed

Pegylated Interferon Alfa-2a for Dialysis Patients With Acute Hepatitis C

Hepatitis C

Taiwan

Search clinical trials for: IFN-a-2a

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jamaica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations